2018-08-23T12:16:33-05:00 2017-12-31 271235638 MCM CPAS & ADVISORS LLP 462 S FOURTH ST SUITE 2600 LOUISVILLE KY 402023445 990 2017-01-01 830392250 NATIONAL STEM CELL FOUNDATION INC NATI 5023798544 462 S 4TH STREET NO 1230 LOUISVILLE KY 40202 DR PAULA GRISANTI CHAIRMAN 5023798544 2018-08-15 1 REBECCA L PHILLIPS CPA P00024055 5027491900 2017 2022-09-23 18:48:47Z DR PAULA GRISANTI 462 S 4TH STREET NO 1230 LOUISVILLE KY 40202 7024269 0 X WWW.NATIONALSTEMCELLFOUNDATION.ORG X 2003 DC NSCF FUNDS ADULT STEM CELL RESEARCH, SCHOLARSHIPS FOR MIDDLE-SCHOOL (CONTINUED ON SCHEDULE O)SCIENCE TEACHERS, EFFORTS TO INCREASE THE DONOR POOL FOR BONE MARROW TRANSPLANTS AND PROGRAMS THAT CONNECT CHILDREN WITH LIMITED RESOURCES TO CLINICAL TRIALS FOR RARE DISEASES. 5 3 4 4 0 0 695941 1132282 0 0 44135 111771 0 5292216 740076 6536269 952070 316191 0 0 360727 344900 0 44496 124285 231449 227353 1544246 932940 -804170 5603329 4203563 9455091 1583833 1069086 2619730 8386005 NSCF FUNDS ADULT STEM CELL RESEARCH, SCHOLARSHIPS FOR MIDDLE-SCHOOL SCIENCE TEACHERS, EFFORTS TO INCREASE THE DONOR POOL FOR BONE MARROW TRANSPLANTS AND PROGRAMS THAT CONNECT CHILDREN WITH LIMITED RESOURCES TO CLINICAL TRIALS FOR RARE DISEASES. 0 0 705293 316191 ACCOMPLISHMENTS INCLUDE DEVELOPMENT OF A COLLABORATIVE PROJECT BETWEEN FUNDED RESEARCHERS ON BOTH COASTS GOING TO THE INTERNATIONAL SPACE STATION (ISS) TO ADVANCE SCIENCE IN THE FIELD OF NEURODEGENERATIVE DISEASE. CONNECTING RESEARCH TO EDUCATION, ASTRONAUTS ON THE ISS WILL SPEAK TO STUDENTS IN MIDDLE SCHOOL CLASSROOMS AFFILIATED WITH THE NATIONAL STEM (SCIENCE, TECHNOLOGY, ENGINEERING & MATH) SCHOLAR PROGRAM. THE 2017 DEVELOPMENT OF A SECOND PARTNERSHIP WITH THE ORTHOPAEDIC RESEARCH & EDUCATION FOUNDATION (OREF) TO FUND CLINICAL TRIALS TO REPAIR/REGENERATE BONE, MUSCLE OR TENDONS, AND A NEW FUND AT DUKE UNIVERSITY'S PEDIATRIC BLOOD & MARROW TRANSPLANT (PBMT) PROGRAM TO HELP CHILDREN OF LIMITED MEANS PARTICIPATE IN CLINICAL TRIALS TO ADVANCE RESEARCH INTO THERAPIES FOR RARE DISEASES. 705293 1 1 0 0 0 0 0 0 0 0 1 0 1 0 0 1 1 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 8 0 1 4 1 0 0 0 0 0 0 0 0 0 0 X 5 3 1 1 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 KY X DR PAULA GRISANTI 5023798544 462 S 4TH STREET SUITE 1230 LOUISVILLE KY 40202 PAULA GRISANTI CHAIRMAN AND CEO 40.00 X X 200000 0 12294 C DENNIS RIGGS SECRETARY/TREASURER 1.00 X X 0 0 0 MICHAEL GRISANTI DIRECTOR 2.00 X 0 0 0 BRUCE S WOLFF DIRECTOR 5.00 X 0 0 0 JOHN M CRANOR III DIRECTOR 1.00 X 0 0 0 DIANE CORNWELL CHIEF FINANCIAL OFFICER 1.30 X 12500 0 0 212500 0 12294 1 0 1 0 0 1132282 1132282 49771 49771 550000 488000 62000 62000 62000 SEE SCHEDULE O 900099 5292216 5292216 5292216 6536269 5292216 0 111771 316191 316191 222594 183849 22823 15922 92981 52039 15770 25172 10470 6271 1597 2602 18855 13659 2103 3093 1650 1650 40825 3938 36887 44496 44496 14507 14507 6051 5037 199 815 57067 43122 13945 21199 11021 2850 7328 36498 27543 3872 5083 4376 2139 3 2234 6225 5125 100 1000 16368 12405 1717 2246 22317 21099 906 312 MISCELLANEOUS 270 205 28 37 932940 705293 103362 124285 687371 587855 95815 446865 12654 17415 97358 70559 43167 26799 3086171 2794146 278385 5582011 4203563 9455091 49659 49382 1534174 1019704 1583833 1069086 X 2523841 7939140 95889 446865 2619730 8386005 4203563 9455091 5603329 162946 0 X X 0 1 X 1 0 X 112193 1004349 965688 697650 1132282 3912162 112193 1004349 965688 697650 1132282 3912162 2523777 1388385 550 12061 45957 55306 49771 163645 7830 1572 9402 4085209 5542216 0.33990 0.34790 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 5476 3798 1678 91882 66761 25121 26799 CRITICAL REAGENTS 5582011 C 5582011 X 6708328 162946 9113 172059 6536269 0 6536269 942053 9113 9113 932940 0 932940 PART X, LINE 2: THE FOUNDATION HAS RECEIVED A DETERMINATION LETTER FROM THE INTERNAL REVENUE SERVICE INDICATING THAT IT IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF INTERNAL REVENUE CODE AND IS CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION. ACCORDINGLY, NO PROVISION FOR INCOME TAXES IS INCLUDED IN THE FINANCIAL STATEMENTS. THE FOUNDATION RECOGNIZES UNCERTAIN INCOME TAX POSITIONS USING THE "MORE-LIKELY-THAN-NOT" APPROACH AS DEFINED IN THE ASC. NO LIABILITY FOR UNCERTAIN TAX POSITIONS HAS BEEN RECORDED IN THE ACCOMPANYING FINANCIAL STATEMENTS. X X X 1 ASHLEY ROUNDTREE 2525 NELSON MILLER PKWY STE 106 LOUISVILLE KY 40223 FUNDRAISING CONSULTING 0 0 44496 -44496 44496 -44496 KY 1 SUMMIT FOR STEM CELL FOUNDATION PO BOX 1240 SAN MARCOS CA 92079 474279391 501(C)(3) 100000 SEE PART IV SUPPLEMENTAL INFORMATION MICHAEL J FOX FOUNDATION GRAND CENTRAL STATION PO BOX 4777 NEW YORK NY 10163 134141945 501(C)(3) 100000 SEE PART IV SUPPLEMENTAL INFORMATION NEW YORK STEM CELL FOUNDATION 619 WEST 54TH STREET NEW YORK NY 10019 202905531 501(C)(3) 100000 SEE PART IV SUPPLEMENTAL INFORMATION UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION CONTROLLERS OFFICE LOUISVILLE KY 40292 611029626 501(C)(3) 3161 CRITICAL REAGENTS VALUED AT COST SEE PART IV SUPPLEMENTAL INFORMATION 4 0 PART I, LINE 2: THE ORGANIZATION MEETS REGULARLY WITH REPRESENTATIVES FROM THE GRANT RECIPIENT(S) AND RECEIVES UPDATES AND REPORTS REGARDING EXPENDITURE OF THE FUNDS. PART II, LINE 1, COLUMN (H): NAME OF ORGANIZATION OR GOVERNMENT: SUMMIT FOR STEM CELL FOUNDATION (H) TO INITIATE COVERAGE ON POST-FLIGHT GROUND RESEARCH FOR A COLLABORATION BETWEEN VALENTINA FOSSATI AT THE NEW YORK STEM CELL FOUNDATION AND ANDRES BRATT-LEAL AT THE SCRIPPS RESEARCH INSTITUTE. THIS GRANT WILL ENABLE POST-FLIGHT PARTNERING DISCUSSIONS FOR ONGOING EARTH-BASED RESEARCH. NAME OF ORGANIZATION OR GOVERNMENT: MICHAEL J. FOX FOUNDATION GRAND CENTRAL STATION (H) CONTINUED FUNDING OF THE TRANSLATIONAL WORK OF DR. PENNY HALLETT, DIRECTOR OF THE NEUROREGENERATION INSTITUTE AT HARVARD MEDICAL SCHOOL/MCLEAN HOSPITAL AND DR. OLE ISACSON, FOUNDING DIRECTOR OF THE NEUROREGENERATION INSTITUTE AND PRINCIPAL FACULTY OF THE HARVARD STEM CELL INSTITUTE. RESEARCH IS FOCUSED ON ENGINEERING SKIN STEM CELLS TO BECOME PATIENT-SPECIFIC DOPAMINE-PRODUCING NEURONS, THE GOAL IS TO IMPLANT THE NEURONS DEVELOPED FROM A PATIENT'S OWN SKIN CELLS TO ALLEVIATE OR PREVENT PARKINSON'S MOTOR SYMPTOMS OF TREMOR, RIGIDITY AND SLOWNESS. NAME OF ORGANIZATION OR GOVERNMENT: NEW YORK STEM CELL FOUNDATION (H) TO INITIATE COVERAGE ON POST-FLIGHT GROUND RESEARCH FOR A COLLABORATION BETWEEN ANDRES BRATT-LEAL AT THE SCRIPPS RESEARCH INSTITUTE AND VALENTINA FOSSATI AT THE NEW YORK STEM CELL FOUNDATION. THIS GRANT WILL ENABLE POST-FLIGHT PARTNERING DISCUSSIONS FOR ONGOING EARTH-BASED RESEARCH. NAME OF ORGANIZATION OR GOVERNMENT: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION (H) RESEARCH AND ADVANCEMENT OF CLINICAL TRIALS ASSOCIATED WITH ADULT STEM CELL THERAPIES. X X X X 0 0 0 0 0 0 0 0 0 PAULA GRISANTI CHAIRMAN AND CEO 200000 0 0 0 0 0 0 0 12294 0 212294 0 0 0 X 3 574960 FMV 0 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 PAULA GRISANTI, CHAIRMAN OF THE BOARD, AND MICHAEL GRISANTI, DIRECTOR, HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION A, LINE 3 THE ORGANIZATION HAS CONTRACTED ITS FINANCIAL MANAGEMENT OVERSIGHT TO AN OUTSIDE CHIEF FINANCIAL OFFICER AND ITS DAY TO DAY FINANCIAL DUTIES TO A CONTROLLER. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM AND REVIEWED IN DETAIL BY THE CONTRACT CFO, CONTRACT CONTROLLER, BOARD CHAIR AND FINANCE COMMITTEE. A COPY WAS THEN SENT TO EACH BOARD MEMBER FOR THEIR REVIEW BEFORE THE FORM 990 WAS FILED. FORM 990, PART VI, SECTION B, LINE 12C INTERESTED PERSONS WILL ANNUALLY DISCLOSE OR UPDATE TO THE CHAIRMAN OF THE BOARD OF DIRECTORS ON A FORM PROVIDED BY THE ORGANIZATION THEIR INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, SUCH AS A LIST OF FAMILY MEMBERS, SUBSTANTIAL BUSINESS OR INVESTMENT HOLDINGS AND OTHER TRANSACTIONS OR AFFILIATION WITH BUSINESSES AND OTHER ORGANIZATIONS OR THOSE OF FAMILY MEMBERS. FOR EACH INTEREST DISCLOSED TO THE CHAIRMAN OF THE BOARD OF DIRECTORS, THE CHAIRMAN WILL DETERMINE WHETHER TO: (A) TAKE NO ACTION; (B) ASSURE FULL DISCLOSURE TO THE BOARD OF DIRECTORS AND OTHER INDIVIDUALS COVERED BY THE POLICY; (C) ASK THE PERSON TO RECUSE FROM PARTICIPATION IN RELATED DISCUSSIONS OR DECISION WITHIN THE ORGANIZATION; OR (D) ASK THE PERSON TO RESIGN FROM HIS OR HER POSITION IN THE ORGANIZATION OR, IF THE PERSON REFUSES TO RESIGN, BECOME SUBJECT TO POSSIBLE REMOVAL IN ACCORDANCE WITH THE ORGANIZATION'S REMOVAL PROCEDURES. THE ORGANIZATION'S CHIEF EMPLOYED EXECUTIVE AND CHIEF EMPLOYED FINANCE EXECUTIVE WILL MONITOR PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND DISCLOSE THEM TO THE CHAIRMAN OF THE BOARD OF DIRECTORS IN ORDER TO DEAL WITH POTENTIAL OR ACTUAL CONFLICTS, WHETHER DISCOVERED BEFORE OR AFTER THE TRANSACTION HAS OCCURRED. TO DATE NO POTENTIAL CONFLICTS HAVE BEEN IDENTIFIED. FORM 990, PART VI, SECTION B, LINE 15 IN 2015 THE BOARD ENGAGED AN OUTSIDE CONSULTING FIRM TO DETERMINED AN APPROPRIATE SALARY RANGE FOR THE CHAIR/CEO POSITION. A BOARD APPROVED SALARY WAS ESTABLISHED BASED ON THEIR GUIDANCE AND NO SALARY ADJUSTMENT HAS BEEN MADE SINCE THAT TIME. CONTRACTED CFO AND CONTRACTED CONTROLLER ARE PAID ON AN HOURLY BASIS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. THE ORGANIZATION'S BOARD OF DIRECTORS CONTINUE TO SELECT THE INDEPENDENT ACCOUNTANT. THE COMMITTEE CONTINUES TO MEET WITH THE INDEPENDENT AUDITOR AT THE CONCLUSION OF THE ANNUAL AUDIT. PART VIII, LINE 11A OTHER GAIN OR (LOSS) DURING THE YEAR A SUBLICENSE AGREEMENT WAS TERMINATED BY THE SUBLICENSEE. AS PART OF THE TERMINATION, THE UNUSED CRITICAL REAGENTS WERE RETURNED TO THE FOUNDATION. THE AMOUNT OF GAIN REFLECTS THE INITIAL AMOUNT RECEIVED LESS THE USE OF A PORTION OF THE CRITICAL REAGENTS BY THE OUTSIDE THIRD PARTY DURING THE PERIOD THE SUBLICENSE AGREEMENT WAS IN EFFECT PRIOR TO TERMINATION.